Latest Movers & Shakers in ICU

AOP Health: Roland Bindeus becomes Senior Director Commercial

AOP Health: Roland Bindeus becomes Senior Director Commercial

The Vienna-based pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health), which specializes in rare diseases and critical care medicine ,  is repositioning itself strategically. In order to offer patients and healthcare professionals state-of-the-art therapy concepts not only today

Read more
Essentia Health-Fargo Welcomes Critical Care Specialist Dr. Shu Xian (Suzanne) Lee

Essentia Health-Fargo Welcomes Critical Care Specialist Dr. Shu Xian (Suzanne) Lee

Essentia Health-Fargo is proud to welcome Dr. Shu Xian (Suzanne) Lee, who specializes in critical care.   “I was drawn to practice at Essentia Health because of the camaraderie I witnessed amongst the staff, and I felt very welcomed to the community,” said Dr. Lee. “I do not have persona

Read more
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors

Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of bio

Read more
Jeanette Hedén Carlsson Resigns as Executive Vice President Brand & Communication at Getinge

Jeanette Hedén Carlsson Resigns as Executive Vice President Brand & Communication at Getinge

Getinge announces that Jeanette Hedén Carlsson has decided to resign after 6 years as Executive Vice President, Brand & Communication, and member of the Executive Team. The process to recruit a successor will start immediately.   ”Jeanette has successfully built and developed effecti

Read more
Fresenius Appoints Robert Möller to the Management Board

Fresenius Appoints Robert Möller to the Management Board

Robert Möller appointed to the Fresenius Management Board; at the same time, Möller will assume responsibility for hospital group as CEO of Helios Health GmbH  Dr. Francesco De Meo leaves the company  Management Board team continues to drive froward transformation on the way to #

Read more
Marion Rottenberg is the New International Patient Advocacy Lead at AOP Health

Marion Rottenberg is the New International Patient Advocacy Lead at AOP Health

The Vienna native has a wealth of experience in pharma and will be building up the European pioneer’s area of Patient Advocacy in the field of rare diseases and intensive care.   As of June 2023, Marion Rottenberg has taken over the role of International Patient Advocacy Lead at AOP Heal

Read more
Dr. George Goshua Appointed to Annals of Internal Medicine Editorial Board

Dr. George Goshua Appointed to Annals of Internal Medicine Editorial Board

George Goshua, MD, MSc, Assistant Professor of Medicine (Hematology) within the Classical Hematology Program at Smilow Cancer Hospital and Yale Cancer Center, has been invited to join the  Annals of Internal Medicine  Editorial Board for a 3-year term, effective July 1, 2023. Established

Read more
https://www.abem.org/public/news-events/abem-news/2023/07/24/ramon-w.-johnson-m.d.-m.b.a.-becomes-president-of-abem

Ramon W. Johnson, M.D., M.B.A, Becomes ABEM President

Ramon W. Johnson, M.D., M.B.A., is the new President of the American Board of Emergency Medicine (ABEM). Dr. Johnson has been an oral examiner since 1993 and has been a member of the Board of Directors since July 2015. He has served ABEM in a number of capacities, including as a Chief Examiner for

Read more
Fresenius Medical Care appoints Martin Fischer as Chief Financial Officer

Fresenius Medical Care appoints Martin Fischer as Chief Financial Officer

Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023. He will succeed Helen Giza who was appointed as Chief Executive Officer and Chair of the Management B

Read more
Replicate Bioscience Appoints Rachael Lester as Chief Business Officer

Replicate Bioscience Appoints Rachael Lester as Chief Business Officer

Biopharma executive with more than 20 years of global corporate, business development, and commercial strategy experience to join Replicate leadership team   Replicate Bioscience, a company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology,

Read more

Highlighted Products